CHAPEL HILL, NC – Matthew Milowsky, MD, associate professor and co-director of the Urologic Oncology Program at UNC Lineberger Comprehensive Cancer Center, has been appointed as the clinic medical director of the N.C. Cancer Hospital.
“We could not invent a better person for this role,” said Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital. “Matt is smart, thoughtful, a terrific doctor, and a true problem-solver, key attributes in this time of rapid change in our system and in health care in general.”
In this role, Dr. Milowsky will be responsible for the clinical policies of the nationally ranked cancer hospital, working in conjunction with clinic management to ensure the most effective, accessible and high quality care for patients.
“Dr. Milowsky’s combination of clinical acumen, patient-centered care and research expertise will assure our patients will be treated in a timely, innovative and compassionate manner,” said Shelley Earp, MD, director of UNC Cancer Care.
“I am excited to take on the role of medical director serving as both a member of the N.C. Cancer Hospital’s Executive Committee and co-chair of the Operations Committee. My goal is to work together to streamline and improve the clinical operations for our patients,” said Milowsky.
Joining UNC in 2011, Dr. Milowsky brings a passion for clinical and translational research with a strong focus on the development of clinical trials and novel treatments for patients with genitourinary cancers. Dr. Milowsky has published in peer-reviewed journals and written several book chapters. He served as an author on the Genitourinary Cancers section of the ASCO Medical Oncology Self-Evaluation Program, and recently was appointed as an associate editor for the 5th edition of the publication.
Named to “Best Doctors in America” the last two years in a row, Dr. Milowsky has received several honors and awards including the Henry Shepard Bladder Cancer Research Award and the MSKCC Paul Sherlock Housestaff Teaching Award. As an active member of the bladder cancer advocacy community, Dr. Milowsky also serves on the BCAN Scientific Advisory Board, an international group of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada.
He completed a fellowship in Medical Oncology and Hematology at the New York Presbyterian Hospital (NYPH)-Weill Medical College of Cornell University. After completing his fellowship training, he remained on staff at New York Presbyterian Hospital-Cornell and focused on the treatment of patients with and research related to genitourinary malignancies. At Cornell, he became the Director of the Genitourinary Oncology Research Program. He subsequently joined the Genitourinary Oncology Service at Memorial-Sloan Kettering Cancer Center and led the translational research program related to urothelial cancers with a focus on the development of novel targeted therapies for patients with advanced bladder cancer.
Media Contact: Katy Jones, UNC Lineberger Comprehensive Cancer Center’s Director of Communications and Marketing, at firstname.lastname@example.org or 919-883-7848.